Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/16301| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Danilova, Bojana | en_US |
| dc.contributor.author | Tonic Ribarska, Jasmina | en_US |
| dc.contributor.author | Trajkovic Jolevska, Suzana | en_US |
| dc.contributor.author | Brezovska, Katerina | en_US |
| dc.contributor.author | Lazova, Jelena | en_US |
| dc.date.accessioned | 2022-01-26T10:35:31Z | - |
| dc.date.available | 2022-01-26T10:35:31Z | - |
| dc.date.issued | 2020-10-29 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/16301 | - |
| dc.language.iso | en | en_US |
| dc.publisher | Macedonian Pharmaceutical Association | en_US |
| dc.relation.ispartof | Macedonian Pharmaceutical Bulletin | en_US |
| dc.title | Regulatory approaches for medicines containing established active substances in USA | en_US |
| dc.type | Journal Article | en_US |
| dc.identifier.doi | 10.33320/maced.pharm.bull.2020.66.03.081 | - |
| dc.identifier.url | http://bulletin.mfd.org.mk/volumes/Volume%2066_3/66_3_081.pdf | - |
| dc.identifier.volume | 66 | - |
| dc.identifier.issue | 03 | - |
| item.grantfulltext | none | - |
| item.fulltext | No Fulltext | - |
| crisitem.author.dept | Faculty of Pharmacy | - |
| Appears in Collections: | Faculty of Pharmacy: Journal Articles | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.